Stay updated with breaking news from Supernus Pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Most readers would already know that Supernus Pharmaceuticals' (NASDAQ:SUPN) stock increased by 9.4% over the past...
Operator: Good afternoon, and welcome to Supernus Pharmaceuticals Third Quarter 2023 Financial Results Conference Call. At this time all participants are in a listen-only mode.
In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...
Supernus Pharmaceuticals' revenue mix is shifting, and it could soon have more sales on the way.
Operator: Good afternoon, and welcome to Supernus Pharmaceuticals First Quarter 2023 Financial Results Conference Call. At this time all participants are in a listen-only mode.